Dr. Paul Chapman, MD
Dr. Paul Chapman, MD
Clinical Director, Memorial Sloan Kettering Cancer Center
Doctor of Medicine, Weill Medical College of Cornell University
Dr. Paul B. Chapman has 35 years of experience in the field of Internal Medicine and Medical Oncology. He earned his BA from Cornell University and his MD from Weill Medical College Cornell University. After completing his residency in Internal Medicine at the University of Chicago Medical Center, he went on to complete a fellowship in Medical Oncology at Memorial Sloan Kettering Cancer Center. Today, this expert is board certified in Internal Medicine and Medical Oncology. Formerly, this expert held roles as an Associate Professor of Medicine at Weill Cornell Medical College and as an Associate Attending Physician at Memorial Sloan Kettering Cancer Center. Currently, he serves as a Professor of Medicine at Weill Cornell Medical College and as an Attending Physician at Memorial Sloan Kettering Cancer Center.
c*********@m*****.org
(212) ***-****
New York, New York
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Radar Metrics At A Glance
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
227
Media & News
730
Social Media Mentions
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Expert Witness Activity
Case Name | Role | Filed Date |
|---|
Unlock Dr. Paul Chapman, MD's full profile
Litigation Analytics
Retained By
Defense
Plaintiff
Activity over time
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
Activity by state
Case Outcome
0
25
50
75
100
Publications
Radar found 227 records
Title | Type |
|---|---|
Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy | Journal Article |
Homophilic binding of mouse monoclonal antibodies against GD3 ganglioside | Journal Article |
Management of immune-related cutaneous adverse events with dupilumab | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Media & News
Radar found 730 records
Title | Description |
|---|---|
General Surgery Perspective - Index | Paul Chapman from Memorial Sloan-Kettering Cancer Center looks back at the ... Medscape Internal Medicine , March 03, 2014. 11. Think Chemo for Isolated ... |
Intralesional Therapy for Melanoma Effective, May Have ... | Jun 2, 2024 ----- ... Clinical Oncology opens in a new tab or window (ASCO) meeting. ... Paul Chapman , MD, of Memorial Sloan Kettering Cancer Center in New York City. |
Targeted therapy combination extends survival in BRAF | Jun 1, 2024 ----- Hematology / Oncology ... Paul B. Chapman , MD, chief medical research ... Presented at: ASCO Annual Meeting 2024; May 31-June 4, 2024: Chicago. |
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
Education
Institution | Degree Type |
|---|---|
Weill Medical College of Cornell University | Doctor of Medicine |
Cornell University | Bachelor of Arts |
Work History
Title | Employer |
|---|---|
Clinical Director | Memorial Sloan Kettering Cancer Center |
Professor | Weill Cornell Medical College |
Attending Physician | Memorial Sloan Kettering Cancer Center |
What to expect from a Radar profile
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 3-5 days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.
